Normal-weight individuals reporting reduced joint pain, improved autoimmune symptoms, decreased brain fog, and normalized menstrual cycles with zero change on the scale
This way, they can focus on effective and sustainable health improvements rather than just a single number
The latest news, trends, analysis, interviews and podcasts from the global food and beverage industry The UK has become the first country in Europe to approve Novo Nordisks Wegovy semaglutide tablet for weight management, a move expected to increase GLP-1 medication use and continue to reshape UK consumers grocery spending behaviours
Reducing insulin resistance through GLP-1 therapy can partially address these androgenic effects, which is part of why GLP-1 medications have attracted interest in the PCOS community
GLP-1 dose increases can only take you so far
Avoid lotions or oils